DLH HOLDINGS CORP (DLHC) Fundamental Analysis & Valuation

NASDAQ:DLHC • US23335Q1004

Current stock price

5.99 USD
+0.02 (+0.34%)
Last:

This DLHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. DLHC Profitability Analysis

1.1 Basic Checks

  • DLHC had negative earnings in the past year.
  • DLHC had a positive operating cash flow in the past year.
  • DLHC had positive earnings in each of the past 5 years.
  • DLHC had a positive operating cash flow in each of the past 5 years.
DLHC Yearly Net Income VS EBIT VS OCF VS FCFDLHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

1.2 Ratios

  • DLHC has a Return On Assets (-0.38%) which is comparable to the rest of the industry.
  • DLHC has a Return On Equity (-0.96%) which is comparable to the rest of the industry.
  • DLHC's Return On Invested Capital of 4.49% is in line compared to the rest of the industry. DLHC outperforms 47.13% of its industry peers.
  • DLHC had an Average Return On Invested Capital over the past 3 years of 7.48%. This is significantly below the industry average of 12.78%.
Industry RankSector Rank
ROA -0.38%
ROE -0.96%
ROIC 4.49%
ROA(3y)1.08%
ROA(5y)4.44%
ROE(3y)3.12%
ROE(5y)10.02%
ROIC(3y)7.48%
ROIC(5y)11.41%
DLHC Yearly ROA, ROE, ROICDLHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • In the last couple of years the Profit Margin of DLHC has declined.
  • DLHC has a Operating Margin (3.90%) which is in line with its industry peers.
  • DLHC's Operating Margin has declined in the last couple of years.
  • DLHC's Gross Margin of 18.68% is on the low side compared to the rest of the industry. DLHC is outperformed by 74.71% of its industry peers.
  • DLHC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.9%
PM (TTM) N/A
GM 18.68%
OM growth 3Y-17.18%
OM growth 5Y-6.68%
PM growth 3Y-59.37%
PM growth 5Y-34.95%
GM growth 3Y1.12%
GM growth 5Y-2.8%
DLHC Yearly Profit, Operating, Gross MarginsDLHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1

2. DLHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DLHC is destroying value.
  • The number of shares outstanding for DLHC has been increased compared to 1 year ago.
  • Compared to 5 years ago, DLHC has more shares outstanding
  • DLHC has a better debt/assets ratio than last year.
DLHC Yearly Shares OutstandingDLHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
DLHC Yearly Total Debt VS Total AssetsDLHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • DLHC has an Altman-Z score of 1.63. This is a bad value and indicates that DLHC is not financially healthy and even has some risk of bankruptcy.
  • DLHC has a Altman-Z score (1.63) which is in line with its industry peers.
  • DLHC has a debt to FCF ratio of 4.41. This is a neutral value as DLHC would need 4.41 years to pay back of all of its debts.
  • DLHC has a Debt to FCF ratio of 4.41. This is comparable to the rest of the industry: DLHC outperforms 54.02% of its industry peers.
  • A Debt/Equity ratio of 1.03 is on the high side and indicates that DLHC has dependencies on debt financing.
  • The Debt to Equity ratio of DLHC (1.03) is worse than 71.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.41
Altman-Z 1.63
ROIC/WACC0.44
WACC10.21%
DLHC Yearly LT Debt VS Equity VS FCFDLHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.3 Liquidity

  • DLHC has a Current Ratio of 0.97. This is a bad value and indicates that DLHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of DLHC (0.97) is worse than 79.31% of its industry peers.
  • DLHC has a Quick Ratio of 0.97. This is a bad value and indicates that DLHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.97, DLHC is not doing good in the industry: 79.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
DLHC Yearly Current Assets VS Current LiabilitesDLHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

1

3. DLHC Growth Analysis

3.1 Past

  • DLHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -104.55%.
  • The earnings per share for DLHC have been decreasing by -29.88% on average. This is quite bad
  • DLHC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.04%.
  • The Revenue has been growing by 10.49% on average over the past years. This is quite good.
EPS 1Y (TTM)-104.55%
EPS 3Y-57.47%
EPS 5Y-29.88%
EPS Q2Q%-150%
Revenue 1Y (TTM)-17.04%
Revenue growth 3Y-4.47%
Revenue growth 5Y10.49%
Sales Q2Q%-24.11%

3.2 Future

  • Based on estimates for the next years, DLHC will show a very negative growth in Earnings Per Share. The EPS will decrease by -120.36% on average per year.
  • DLHC is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -17.69% yearly.
EPS Next Y-569.2%
EPS Next 2Y-120.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-32.28%
Revenue Next 2Y-17.69%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DLHC Yearly Revenue VS EstimatesDLHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
DLHC Yearly EPS VS EstimatesDLHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

2

4. DLHC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DLHC. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DLHC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DLHC Price Earnings VS Forward Price EarningsDLHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

  • 77.01% of the companies in the same industry are more expensive than DLHC, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, DLHC is valued cheaper than 97.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.87
EV/EBITDA 7.39
DLHC Per share dataDLHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • A cheap valuation may be justified as DLHC's earnings are expected to decrease with -120.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-120.36%
EPS Next 3YN/A

0

5. DLHC Dividend Analysis

5.1 Amount

  • DLHC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DLHC Fundamentals: All Metrics, Ratios and Statistics

DLH HOLDINGS CORP

NASDAQ:DLHC (3/13/2026, 8:21:18 PM)

5.99

+0.02 (+0.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-09
Earnings (Next)05-05
Inst Owners67.55%
Inst Owner Change2.25%
Ins Owners12.42%
Ins Owner Change2.5%
Market Cap86.80M
Revenue(TTM)322.61M
Net Income(TTM)-1.08M
Analysts82.86
Price Target10.2 (70.28%)
Short Float %0.53%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-126.05%
Min EPS beat(2)-296.08%
Max EPS beat(2)43.98%
EPS beat(4)1
Avg EPS beat(4)-67.51%
Min EPS beat(4)-296.08%
Max EPS beat(4)43.98%
EPS beat(8)3
Avg EPS beat(8)-33.61%
EPS beat(12)6
Avg EPS beat(12)-22.6%
EPS beat(16)9
Avg EPS beat(16)-9.67%
Revenue beat(2)0
Avg Revenue beat(2)-4.53%
Min Revenue beat(2)-5.28%
Max Revenue beat(2)-3.79%
Revenue beat(4)0
Avg Revenue beat(4)-3.36%
Min Revenue beat(4)-5.28%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-4.03%
Revenue beat(12)1
Avg Revenue beat(12)-4.06%
Revenue beat(16)2
Avg Revenue beat(16)-3.11%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-31.43%
EPS NY rev (3m)-70.37%
Revenue NQ rev (1m)-10.77%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-4.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF 2.87
P/OCF 2.89
P/B 0.77
P/tB N/A
EV/EBITDA 7.39
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)2.09
FCFY34.86%
OCF(TTM)2.07
OCFY34.55%
SpS22.26
BVpS7.74
TBVpS-7.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.38%
ROE -0.96%
ROCE 5.19%
ROIC 4.49%
ROICexc 4.5%
ROICexgc 66.78%
OM 3.9%
PM (TTM) N/A
GM 18.68%
FCFM 9.38%
ROA(3y)1.08%
ROA(5y)4.44%
ROE(3y)3.12%
ROE(5y)10.02%
ROIC(3y)7.48%
ROIC(5y)11.41%
ROICexc(3y)7.49%
ROICexc(5y)11.97%
ROICexgc(3y)141.56%
ROICexgc(5y)N/A
ROCE(3y)8.65%
ROCE(5y)13.18%
ROICexgc growth 3Y-13.01%
ROICexgc growth 5Y-1.07%
ROICexc growth 3Y-36.15%
ROICexc growth 5Y-8.79%
OM growth 3Y-17.18%
OM growth 5Y-6.68%
PM growth 3Y-59.37%
PM growth 5Y-34.95%
GM growth 3Y1.12%
GM growth 5Y-2.8%
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 4.41
Debt/EBITDA 3.9
Cap/Depr 1.58%
Cap/Sales 0.08%
Interest Coverage 0.97
Cash Conversion 100.76%
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 1.63
F-Score4
WACC10.21%
ROIC/WACC0.44
Cap/Depr(3y)3.44%
Cap/Depr(5y)4.59%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.14%
Profit Quality(3y)1375.61%
Profit Quality(5y)915.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-104.55%
EPS 3Y-57.47%
EPS 5Y-29.88%
EPS Q2Q%-150%
EPS Next Y-569.2%
EPS Next 2Y-120.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.04%
Revenue growth 3Y-4.47%
Revenue growth 5Y10.49%
Sales Q2Q%-24.11%
Revenue Next Year-32.28%
Revenue Next 2Y-17.69%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-46.94%
EBIT growth 3Y-20.88%
EBIT growth 5Y3.11%
EBIT Next Year17.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.16%
FCF growth 3Y295.63%
FCF growth 5Y3.55%
OCF growth 1Y6.59%
OCF growth 3Y165.32%
OCF growth 5Y3.6%

DLH HOLDINGS CORP / DLHC Fundamental Analysis FAQ

What is the fundamental rating for DLHC stock?

ChartMill assigns a fundamental rating of 2 / 10 to DLHC.


What is the valuation status of DLH HOLDINGS CORP (DLHC) stock?

ChartMill assigns a valuation rating of 2 / 10 to DLH HOLDINGS CORP (DLHC). This can be considered as Overvalued.


What is the profitability of DLHC stock?

DLH HOLDINGS CORP (DLHC) has a profitability rating of 3 / 10.


How financially healthy is DLH HOLDINGS CORP?

The financial health rating of DLH HOLDINGS CORP (DLHC) is 1 / 10.